CXCL10 and dermatomyositis: Both cross‐sectionally and longitudinally, galectin‐9 and CXCL10 outperformed CK, which is commonly used as a laboratory marker for disease activity and is one of the current criteria for determining clinically inactive disease in juvenile DM 42, 51.